Swiss National Bank Eq Rx, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.61 - $1.96 $261,625 - $318,500	162,500 Added 51.39%	478,700 $890,000
Q1 2023 May 10, 2023	SELL	$1.8 - $2.83 $66,600 - $104,710	-37,000 Reduced 10.48%	316,200 $613,000
Q4 2022 Feb 08, 2023	BUY	$2.05 - $5.5 $17,835 - $47,850	8,700 Added 2.53%	353,200 $868,000
Q2 2022 Aug 09, 2022	BUY	$3.2 - $5.69 $1.1 Million - $1.96 Million	344,500 New	344,500 $1.62 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.